Sales of Drug-Spiked Nicotine Could Sink E-Cigarettes' Smoking Cessation Chances

Since Commissioner Gottlieb's appointment, US FDA has challenged END industry more aggressively to eliminate products and advertising targeting children and has said sales to minors could be a focal point of an FDA action to ban all e-cigarette sales. Finding pharmaceutical ingredients in liquid nicotine could make a general ban on e-cigarette sales more likely in addition to imperiling approval for a smoking cessation indication.

A Chinese firm is casting a shadow over electronic cigarettes' chances in the US to be approved as medical products for smoking cessation as well as potentially over the entire industry's future by selling liquid nicotine spiked with erectile dysfunction drugs.

A warning letter to Shanghai HelloCig Electronic Technology Co. Ltd. that US FDA published on Oct. 11 states that the...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from China

Check Contract Manufacturers' GMP Compliance, US FDA Warns Eye Drop Firm, Lip Balm Provider

 

Request to recall eye drops should be fulfilled promptly and businesses providing lip balms as promotional products must verify contract manufacturers are compliant, recent FDA warnings states. Additional letters went to Jordanian firm about testing alcohol for methane and to a Chinese firm advised that compliance with China’s quality control standards isn’t sufficient.

Kenvue Increases Marketing Spend To Boost Consumer Loyalty, Expand Reach To More

 

Kenvue maintains full-year guidance after 0.3% Q2 net sales dip beat market expectations. Essential health segment alone drove sales; self-care and skin health/beauty faltered. US sales of Neutrogena Collagen Bank pre-aging platform launched on TikTok shop, a first for the brand.

L’Oréal’s ‘Robust’ European Sales Offset US Slowdown, Continued Weakness In China

 

L’Oréal's European business recorded sales growth of 9.7% to €3.55bn in the second quarter as consumer confidence grows, while in the US sales slowed for the dermatological beauty business and consumers in China are value-shopping.

Lingering Headwinds Slow Latest Results, But P&G Rebuffs Concerns About Consumer Spending

 

P&G's FY2024 Q4 net sales were flat at $20.5bn, lower than consensus estimates, but the firm says its underlying business divisions are healthy and forecasts FY2025 sales up 2% to 4%, up 3% to 5% organically.

More from Asia

Kenvue Increases Marketing Spend To Boost Consumer Loyalty, Expand Reach To More

 

Kenvue maintains full-year guidance after 0.3% Q2 net sales dip beat market expectations. Essential health segment alone drove sales; self-care and skin health/beauty faltered. US sales of Neutrogena Collagen Bank pre-aging platform launched on TikTok shop, a first for the brand.

L’Oréal’s ‘Robust’ European Sales Offset US Slowdown, Continued Weakness In China

 

L’Oréal's European business recorded sales growth of 9.7% to €3.55bn in the second quarter as consumer confidence grows, while in the US sales slowed for the dermatological beauty business and consumers in China are value-shopping.

EL Companies CFO; L'Oreal Skinceuticals Expanding In Japan; And More, Personal Care News Briefs

 

Estee Lauder Companies taps a CFO; L’Oréal SA expands SkinCeuticals brand in Japan through Cutera partnership; IFF's Shanghai Creative Center operational by September; vegan hair care brand Naturaz expanding retail with seed funding; American Exchange Group acquires Indie Lee; and US men using skin care up 68% since 2022.